Europol calls India out for not policing drug counterfeiters; CPhI adds experts from Catalent, Piramal, IMS;

> A new report written in part by Europol takes India to task for not doing more to interrupt the manufacture of counterfeit meds that are ending up in Europe. Report

> CPhI has added Kurt Nielson of Catalent ($CTLT); Vivek Sharma of Piramal; and Alan Sheppard of IMS Health ($IMS) to its panel of experts for evaluating supply-chain trends. Release

> The European Federation of Pharmaceutical Industries and Associations says more flexibility in the EU's GMP guidance on qualification and validation would promote new technologies in the future. Report